Structures by: Wagner A.
Total: 20
C33H52O3
C33H52O3
Journal of medicinal chemistry (2010) 53, 1 178-190
a=7.2672(2)Å b=11.8653(3)Å c=33.6544(9)Å
α=90.00° β=90.00° γ=90.00°
C12H10Cl2O2
C12H10Cl2O2
Organic & Biomolecular Chemistry (2009) 7, 9 1771-1774
a=7.2064(2)Å b=7.7304(4)Å c=21.6681(10)Å
α=90.00° β=99.591(3)° γ=90.00°
C11H11ClO3
C11H11ClO3
Organic & Biomolecular Chemistry (2009) 7, 9 1771-1774
a=7.5568(9)Å b=5.6463(8)Å c=12.8318(11)Å
α=90.00° β=92.578(7)° γ=90.00°
C19H26O2
C19H26O2
Chemical communications (Cambridge, England) (2010) 46, 31 5778-5780
a=19.4535(11)Å b=7.3089(3)Å c=22.1934(12)Å
α=90.00° β=96.279(2)° γ=90.00°
C46H46O2P2Pt2Te4,C7H8
C46H46O2P2Pt2Te4,C7H8
Dalton Transactions (2008) 27 3535-3537
a=11.904(2)Å b=15.039(3)Å c=16.760(3)Å
α=86.35(3)° β=81.87(3)° γ=67.62(3)°
C39H34OP2PtTe2
C39H34OP2PtTe2
Dalton Transactions (2008) 27 3535-3537
a=16.993(3)Å b=10.613(2)Å c=18.855(4)Å
α=90.00° β=92.74(3)° γ=90.00°
C26H50Br4Cu2N12
C26H50Br4Cu2N12
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15828-15839
a=9.745(2)Å b=15.441(3)Å c=15.747(3)Å
α=90.00° β=99.30(3)° γ=90.00°
C25H49Cl8Cu4N13
C25H49Cl8Cu4N13
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15828-15839
a=8.9110(18)Å b=11.271(2)Å c=12.327(3)Å
α=68.28(3)° β=75.70(3)° γ=77.19(3)°
C28H53.5Cl6Cu3N14.5
C28H53.5Cl6Cu3N14.5
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15828-15839
a=10.468(2)Å b=11.042(2)Å c=12.834(3)Å
α=113.89(3)° β=104.28(3)° γ=95.38(3)°
C26H50Cl4Cu2N12
C26H50Cl4Cu2N12
Dalton transactions (Cambridge, England : 2003) (2016) 45, 40 15828-15839
a=6.5350(13)Å b=20.853(4)Å c=13.101(3)Å
α=90° β=98.89(3)° γ=90°
C18H24NOP
C18H24NOP
Chemical communications (Cambridge, England) (2010) 46, 12 2139-2141
a=8.6513(4)Å b=19.0107(10)Å c=10.3315(4)Å
α=90.00° β=90.445(2)° γ=90.00°
C22H36N6O7
C22H36N6O7
Acta Crystallographica Section B (2002) 58, 4 721-727
a=10.1280(10)Å b=12.4860(10)Å c=19.5070(10)Å
α=90.000° β=90.000° γ=90.000°
C22H36N6O7
C22H36N6O7
Acta Crystallographica Section B (2002) 58, 4 721-727
a=10.1270(10)Å b=12.5010(10)Å c=19.4950(10)Å
α=90.000° β=90.000° γ=90.000°
Di-μ-furan-2-selenolato-bis[(furan-2-selenolato)(triphenylphosphine)palladium]
C52H42O4P2Pd2Se4
Acta Crystallographica Section E (2005) 61, 11 m2198-m2200
a=13.045(3)Å b=16.394(3)Å c=12.233(2)Å
α=90.00° β=110.85(3)° γ=90.00°
2,4,6,8-tertaphenylbarbaralane
C33H26
Acta Crystallographica Section A Foundations of Crystallography (2004) 60, 5 390-396
a=26.232(5)Å b=10.399(2)Å c=19.618(4)Å
α=90.000° β=119.45(3)° γ=90.000°
C9H12N2O
C9H12N2O
The Journal of organic chemistry (2015) 80, 5 2848-2854
a=6.6807(5)Å b=7.3529(6)Å c=17.0246(13)Å
α=90.00° β=90.00° γ=90.00°
C19H26O2
C19H26O2
Journal of Organic Chemistry (2011) 76, 3274-3285
a=19.4535(11)Å b=7.3089(3)Å c=22.1934(12)Å
α=90.00° β=96.279(2)° γ=90.00°
3(C18H18O5),CHCl3
3(C18H18O5),CHCl3
Zeitschrift für Kristallographie - New Crystal Structures (2004) 219, 4 492-494
a=18.980(3)Å b=12.345(2)Å c=21.746(5)Å
α=90° β=92.396(16)° γ=90°
C19H20O6·2CHCl3
C19H20O6·2CHCl3
Zeitschrift für Kristallographie - New Crystal Structures (2004) 219, 4 495-496
a=8.7170(17)Å b=10.135(2)Å c=15.358(3)Å
α=99.50(3)° β=99.64(3)° γ=107.38(3)°
Bis-hydrogenbetaine tetrachlorocuprate(II) monohydrate
C10H26Cl4CuN2O5
Zeitschrift für Kristallographie - New Crystal Structures (2006) 221, 4 525-526
a=14.0527(15)Å b=9.1089(7)Å c=16.4085(17)Å
α=90.00° β=105.013(9)° γ=90.00°